Tetsuya Terasaki

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

CPT: pharmacometrics & systems pharmacology

Molecular pharmaceutics

Cells

Journal of neurochemistry

Tohoku Universit

University of Tokyo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tohoku Universit Apr 01 2008 - Mar 31 2020

Japan

Tohoku University Distinguished Professor :: Molecular Pharmaceutics, Membrane Transport and Drug Targeting

Tohoku University Apr 01 1996 - Mar 31 2020

Japan

Professor :: Molecular Pharmaceutics, Membrane Transport and Drug Delivery Laboratory

University of Tokyo Oct 01 1992 - Mar 31 1996

Japan

Associate Professor :: Molecular Pharmaceutics

Kanazawa University Apr 01 1990 - Sep 30 1992

Japan

Associate Professor :: Pharmaceutics

Kanazawa University Apr 01 1985 - Mar 31 1990

Japan

Senior Assitant Professor (Lecturer) :: Pharmaceutics

University of California, Los Angeles Jul 01 1985 - Jun 30 1987

United States

Visiting Assitant Research Fellow :: Medicine,

Kanazawa University Apr 01 1982 - Mar 31 1985

Japan

Assistant Professor :: Pharmaceutics

Education History

University of Tokyo Apr 01 1979 - Mar 31 1982

Japan

PHD :: Pharmaceutics

Kanazawa University, Graduate School of Pharmaceutical Sciences Apr 01 1977 - Mar 31 1979

Japan

MSC :: Pharmaceutics

Kanazawa University Apr 01 1973 - Mar 31 1977

Japan

BSC :: Pharmaceutics

Publications

Luna Prieto Garcia, Anna Vildhede, Pär Nordell, Christine Ahlström, Ahmed B Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Luna Prieto Garcia, Anna Vildhede, Pär Nordell, Christine Ahlström, Ahmed B Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Luna Prieto Garcia, Anna Vildhede, Pär Nordell, Christine Ahlström, Ahmed B Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Luna Prieto Garcia, Anna Vildhede, Pär Nordell, Christine Ahlström, Ahmed B Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. CPT: pharmacometrics & systems pharmacology (2024)
Marie-Pierre Dehouck, Masanori Tachikawa, Yutaro Hoshi, Kotaro Omori, Claude-Alain Maurage, Guillaume Strecker, Lucie Dehouck, Marie-Christine Boucau, Yasuo Uchida, Fabien Gosselet, Tetsuya Terasaki, Yannis Karamanos
Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells. Cells 11 (24) (2022)
Marie-Pierre Dehouck, Masanori Tachikawa, Yutaro Hoshi, Kotaro Omori, Claude-Alain Maurage, Guillaume Strecker, Lucie Dehouck, Marie-Christine Boucau, Yasuo Uchida, Fabien Gosselet, Tetsuya Terasaki, Yannis Karamanos
Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells. Cells 11 (24) (2022)
Toshiki Kurosawa, Yuma Tega, Yasuo Uchida, Kei Higuchi, Hidetsugu Tabata, Takaaki Sumiyoshi, Yoshiyuki Kubo, Tetsuya Terasaki, Yoshiharu Deguchi
Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood-Brain Barrier. Pharmaceutics 14 (8) (2022)
Marie-Pierre Dehouck, Masanori Tachikawa, Yutaro Hoshi, Kotaro Omori, Claude-Alain Maurage, Guillaume Strecker, Lucie Dehouck, Marie-Christine Boucau, Yasuo Uchida, Fabien Gosselet, Tetsuya Terasaki, Yannis Karamanos
Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells. Cells 11 (24) (2022)
Kristiina M Huttunen, Tetsuya Terasaki, Arto Urtti, Ahmed B Montaser, Yasuo Uchida
Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery. Pharmaceutical research 39 (7) (2022)
Marie-Pierre Dehouck, Masanori Tachikawa, Yutaro Hoshi, Kotaro Omori, Claude-Alain Maurage, Guillaume Strecker, Lucie Dehouck, Marie-Christine Boucau, Yasuo Uchida, Fabien Gosselet, Tetsuya Terasaki, Yannis Karamanos
Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells. Cells 11 (24) (2022)
Kenta Tezuka, Masayoshi Suzuki, Risa Sato, Shohei Kawarada, Tetsuya Terasaki, Yasuo Uchida
Activation of Annexin A2 signaling at the blood-brain barrier in a mouse model of multiple sclerosis. Journal of neurochemistry 160 (6) (2022)
Yasuo Uchida, Hina Takeuchi, Ryohei Goto, Clemens Braun, Holger Fuchs, Naoki Ishiguro, Masaki Takao, Mitsutoshi Tano, Tetsuya Terasaki
A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundance. Journal of neurochemistry 161 (2) (2022)
Risa Sato, Kotaro Ohmori, Mina Umetsu, Masaki Takao, Mitsutoshi Tano, Gerald A Grant, Brenda E Porter, Anthony Bet, Tetsuya Terasaki, Yasuo Uchida
An Atlas of the Quantitative Protein Expression of Anti-Epileptic-Drug Transporters, Metabolizing Enzymes and Tight Junctions at the Blood-Brain Barrier in Epileptic Patients. Pharmaceutics 13 (12) (2021)
Yasuo Uchida, Yuta Yagi, Masaki Takao, Mitsutoshi Tano, Mina Umetsu, Satoshi Hirano, Takuya Usui, Masanori Tachikawa, Tetsuya Terasaki
Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood-Brain Barriers at Different Cerebral Regions and the Blood-Spinal Cord Barrier in Humans and Rats. Molecular pharmaceutics 17 (6) (2020)
Yusuke Ochiai, Yasuo Uchida, Masanori Tachikawa, Pierre-Olivier Couraud, Tetsuya Terasaki
Amyloid beta25-35 impairs docosahexaenoic acid efflux by down-regulating fatty acid transport protein 1 (FATP1/SLC27A1) protein expression in human brain capillary endothelial cells. Journal of neurochemistry 150 (4) (2019)
Yuka Yaguchi, Masanori Tachikawa, Zhengyu Zhang, Tetsuya Terasaki
Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats. Molecular pharmaceutics 16 (5) (2019)
Yutaro Hoshi, Yasuo Uchida, Takashi Kuroda, Masanori Tachikawa, Pierre-Olivier Couraud, Takashi Suzuki, Tetsuya Terasaki
Distinct roles of ezrin, radixin and moesin in maintaining the plasma membrane localizations and functions of human blood-brain barrier transporters. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 40 (7) (2019)
Hiroki Kuroda, Masanori Tachikawa, Yuta Yagi, Mina Umetsu, Armania Nurdin, Eisuke Miyauchi, Michitoshi Watanabe, Yasuo Uchida, Tetsuya Terasaki
Cluster of Differentiation 46 Is the Major Receptor in Human Blood-Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28). Molecular pharmaceutics 16 (1) (2018)
Eisuke Miyauchi, Takuya Furuta, Sumio Ohtsuki, Masanori Tachikawa, Yasuo Uchida, Hemragul Sabit, Wataru Obuchi, Tomoko Baba, Michitoshi Watanabe, Tetsuya Terasaki, Mitsutoshi Nakada
Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics. PloS one 13 (3) (2018)
Kazuki Sato, Masanori Tachikawa, Michitoshi Watanabe, Eisuke Miyauchi, Yasuo Uchida, Tetsuya Terasaki
Identification of Blood-Brain Barrier-Permeable Proteins Derived from a Peripheral Organ: In Vivo and in Vitro Evidence of Blood-to-Brain Transport of Creatine Kinase. Molecular pharmaceutics 16 (1) (2018)

Tetsuya Terasaki.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tetsuya Terasaki